Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Kidney International Reports Year : 2018

Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy

Abstract

no abstract

Domains

Genomics [q-bio.GN]
Fichier principal
Vignette du fichier
KidneyIR2018.pdf (910.2 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Pierre RONCO  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02193809

Submitted on : Wednesday, July 24, 2019-5:43:45 PM

Last modification on : Wednesday, April 12, 2023-8:56:20 AM

Download

Dates and versions

inserm-02193809 , version 1 (24-07-2019)

Identifiers

Cite

Lena Berchtold, Gilbert Zanetta, Karine Dahan, Fabrice Mihout, Julie Peltier, et al.. Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy. Kidney International Reports, 2018, 3 (2), pp.486-491. ⟨10.1016/j.ekir.2017.09.009⟩. ⟨inserm-02193809⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-BOURGOGNE U1093 U1155 COMUE-NORMANDIE UNIROUEN SORBONNE-UNIVERSITE SU-MEDECINE
55 View
66 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More